Browse > Article
http://dx.doi.org/10.5487/TR.2013.29.2.087

Safety Evaluation of Topical Valproate Application  

Choi, Sun Young (Department of Dermatology, Chung-Ang University College of Medicine)
Seop, Song Yi (Department of Dermatology, Chung-Ang University College of Medicine)
Hyun, Moo Yeol (Department of Dermatology, Chung-Ang University College of Medicine)
Yoo, Kwang Ho (Department of Dermatology, Chung-Ang University College of Medicine)
Kim, Beom Joon (Department of Dermatology, Chung-Ang University College of Medicine)
Kim, Myeung Nam (Department of Dermatology, Chung-Ang University College of Medicine)
Cho, Jae-We (Department of Dermatology, Keimyung University School of Medicine)
Publication Information
Toxicological Research / v.29, no.2, 2013 , pp. 87-90 More about this Journal
Abstract
The potential role of topical valproate (VPA) in hair regrowth has been recently suggested. However, safety reports of VPA as a topical formulation are lacking. Therefore, in the present study, we investigated whether VPA causes skin irritation in humans. We first performed a cell viability test and showed that VPA did not exhibit toxicity toward HaCaT keratinocytes, fibroblasts, and RBL-3H mast cells. We then performed clinical patch test and skin irritation test through transdermal drug delivery with the help of microneedle rollers. No significant findings were obtained in the clinical patch test. In the skin irritation test, only 1 patient showed erythema at 1 hr, but the irritation reaction faded away within a few hours. Erythema and edema were not observed at 24 hr. We concluded that VPA has minimal potential to elicit skin irritation. Therefore, we consider that VPA can safely be applied to human skin.
Keywords
Valproate; Skin toxicity;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Reynolds, M.F., Sisk, E.C. and Rasgon, N.L. (2007) Valproate and neuroendocrine changes in relation to women treated for epilepsy and bipolar disorder: a review. Curr. Med. Chem., 14, 2799-2812.   DOI   ScienceOn
2 Tennis, P. and Stern, R.S. (1997) Risk of serious cutaneous disorders after initiation of use of phenytoin, carbamazepine, or sodium valproate: a record linkage study. Neurol., 49, 542-546.   DOI   ScienceOn
3 Roujeau, J.C., Kelly, J.P., Naldi, L., Rzany, B., Stern, R.S., Anderson, T., Auquier, A., Bastuji-Garin, S., Correia, O., Locati, F., et al. (1995) Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. N. Engl. J. Med., 333, 1600-1607.   DOI   ScienceOn
4 Lee, S.H., Yoon, J., Shin, S.H., Zahoor, M., Kim, H.J., Park, P.J., Park, W.S., Min do, S., Kim, H.Y. and Choi, K.Y. (2012) Valproic acid induces hair regeneration in murine model and activates alkaline phosphatase activity in human dermal papilla cells. PLoS One, 7, e34152.   DOI   ScienceOn
5 Andl, T., Reddy, S.T., Gaddapara, T. and Millar, S.E. (2002) WNT signals are required for the initiation of hair follicle development. Dev. Cell, 2, 643-653.   DOI   ScienceOn
6 Kishimoto, J., Burgeson, R.E. and Morgan, B.A. (2000) Wnt signaling maintains the hair-inducing activity of the dermal papilla. Genes Dev., 14, 1181-1185.
7 Prausnitz, M.R. (2004) Microneedles for transdermal drug delivery. Adv. Drug Delivery Rev., 56, 581-587.   DOI   ScienceOn
8 Draize, J.H. (1965) The Appraisal of the Safety of Chemicals in Foods, Drugs and Cosmetics, Dermal Toxicity, Association of Food and Drug Officials of the US, Topeka, KA, pp. 46-59.
9 Lachapelle, J.M. (1997) A proposed relevance scoring system for positive allergic patch test reactions: practical implications and limitations. Contact Dermatitis, 36, 39-43.   DOI   ScienceOn
10 Han, T.Y., Park, K.Y., Ahn, J.Y., Kim, S.W., Jung, H.J. and Kim, B.J. (2012) Facial skin barrier function recovery after microneedle transdermal delivery treatment. Dermatol. Surg., 38, 1816-1822.   DOI   ScienceOn